venetoclax,ibrutinib
abbvie,janssen,roche
['ibru', '$jnj']
$jnj new imbruvica (ibrutinib) data in fixed-duration combination regimen presented at eha 2022 shows deep, durable re... 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities